Roo Vold's Colleagues at QED Therapeutics
Roo Vold's Contact Details
HQ
650-231-4088
650-231-4088
Location
Novato,California,United States
Novato,California,United States
Company
QED Therapeutics
QED Therapeutics
Roo Vold's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Roo Vold
Roo Vold currently works for QED Therapeutics.
Roo Vold's role at QED Therapeutics is Senior Vice President, Global Pharmacovigilance.
Roo Vold's email address is ***@qedtx.com. To view Roo Vold's full email address, please signup to ConnectPlex.
Roo Vold works in the Research industry.
Roo Vold's colleagues at QED Therapeutics are Joyce Velez, Richard Jones, Cortney Galasso, Kim Ho, Vanessa Solis, Morgan Paull, Jacki Fontaine and others.
Roo Vold's phone number is 650-231-4088